Kareem Ali Maher (2023) “Cardiovascular Risk Assessment after Sofosbuvir and Daclatasvir Regimen for Chronic Hepatitis C Virus Infection”, Journal of the Pakistan Medical Association, 73(4), pp. S136-S141. doi: 10.47391/JPMA.EGY-S4-28.